Senate Majority Leader Chuck Schumer may dare House Republicans to vote against the $35 per month limit on insulin in the Inflation Reduction Act still under construction, source said The insider.
The sources have not been named to discuss confidential discussions, the newspaper reported on Saturday.
The copay limit is one of the most common components of the law. Senate Democrats hope to pass it using a budget adjustment, allowing them to pass certain bills with a simple majority.
But copay limits may not follow strict procedural rules. The Senate congressman opposed it, a sign that top officials did not believe it was in compliance, Insiders reported.
If congressmen remove it, Democrats have one last chance: force Republicans to raise “order point“To remove it from the law. Democrats could overcome such an objection with 60 votes.
Patent for centuries-old drug, which controls blood sugar levels of millions of country’s diabetics, has been sold by the University of Toronto for $1a move supposedly to ensure cheap insulin to anyone who needs it.
However, prices have increased over time, more than tripling in the last 20 years alone. Many of the country’s more than 8 million diabetics pay thousands a year for life-saving drugs. About 1 million of the country’s type 1 diabetics would have died without it.
Opponents argue that reducing the diabetes copay only changes costs and could lead to increased premiums for all policyholders, as well as costs to the government.
The Associated Press contributed to this report.
Register Fortune feature email list so you don’t miss our biggest features, exclusive interviews and surveys.